- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00715962
Efficacy and Safety of a Hospital Walking Program for Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Low mobility, defined as being limited to bed or chair, is common during acute hospitalization. The candidate's work has demonstrated low mobility to be associated with adverse outcomes including functional decline, need for new nursing home admission, and death even after controlling for illness severity and comorbidity. Objective: Using a Phase II trial design, the impact and safety of a hospital walking program for older patients during acute general medical hospitalization will be evaluated.
Project Design: 100 patients, age 65 years admitted to the medical wards at the Birmingham VAMC will be recruited within 48 hours of hospitalization and followed for 14 days after enrollment or until discharge, which ever comes first. Exclusion criteria will include: (1) Delirious based on positive Confusion Assessment Method (CAM); (2) Mini Mental State Examination Score < 17; (3) Patient on isolation; (4) Inability to ambulate 2 weeks prior to admission; (5) Having a medical diagnosis deemed by the primary physician to be a contraindication to ambulation; (6) patient with an imminently terminal illness; and (7) Non-English speaking. Participants will be randomized to either usual care (UC) or to a hospital walking program (WP), which includes twice daily walks with assistance, provision of necessary ambulatory devices, and a behavioral intervention strategy designed to encourage out of bed activity. Throughout hospitalization, the WP and UC veterans will wear on the ipsilateral thigh and ankle wireless monitors that measure horizontal and vertical orientation with respect to gravity. Previously validated by the candidate to assess levels of mobility during hospitalization, the output will be used to calculate the length of time patients spent lying, sitting, and standing or walking, using pre-defined criteria. Other daily measures will include orthostatic blood pressure, functional assessments, and assessment of falls and symptoms over the previous 24-hours. The primary outcome measure is time out of bed as measured by the wireless monitors. Importantly, our goal is to assess not only the amount of mobility that occurred as a result of the hospital walking program but that which occurred beyond the intervention. In our previous VA-funded study, patients spent an average of 17.1% or 4.1 hours out of bed per 24-hour period of time (s.d. 2.9). Our goal is to increase this by 50% or 2 hours to an average of 6.1 hours. This results in an effect size of 0.69 standard deviation units. A sample size of 45 per group provides 90% power to detect this 2-hour difference in the amount of time patients spend out of bed at the = .05 level.
Significance: at present there is a paucity of data regarding the impact or safety of a hospital walking program for general medical patients. Results of this study will enable researchers to determine the safety and efficacy of the walking program for older veterans during hospitalization and will provide information regarding effect size for a definitive intervention trial.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- VA Medical Center, Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age greater or equal to 65 years;
- Admitted to the Birmingham VAMC for a medical condition
Exclusion Criteria:
- Delirious based on positive Confusion Assessment Method (CAM);
- Mini-Cognitive Assessment score indicating dementia;
- Inability to ambulate 2 weeks prior to admission;
- Having a medical diagnosis deemed by the primary physician to be a contraindication to ambulation;
- patient with an imminently terminal illness; and
- Non-English speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Mobility Group
The Walking Intervention includes assistance to walk twice daily with or without a rolling walker.
In addition, a behavioral intervention that included goal setting and discussion of how to overcome mobility barriers was used to encourage the mobility group to be more active throughout hospital stay.
Participants will keep a diary of out of bed activity and will be encouraged to set goals for additional out of bed activity daily.
|
Using social cognitive theory, participants in the walking program group will be encouraged to complete a brief diary about out of bed activities like sitting up for meals of walks to the bathroom.
They will be provided with information regarding the importance of being out of bed a praise for any attempts.
They will be asked to set out of bed time activity goals daily.
The control group will have a diary to track visitors.
Participants in the walking program will be assisted to walk twice a day by trained staff.
Those in the control group will be visited twice a day for friendly visits only
|
|
Placebo Comparator: Control Group
The control group will receive twice daily friendly visits to counter the attention being paid to the intervention group.
They will complete a diary but of visitors to their room.
|
The control group will receive twice daily friendly visits and will be asked to complete a diary each day of the people who visit them in the hospital.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Falls
Time Frame: 18 months
|
Patients were asked daily during hospitalization to self-report any falls
|
18 months
|
|
Amount of Time Spent Out of Bed as Measured by Wireless Accelerometers
Time Frame: During hospital stay
|
Throughout the hospital stay, both the WP and UC patient wore a triaxial accelerometer on the ipsilateral thigh and ankle.
The patient's skin was assessed regularly to assure there is no evidence of irritation.
The wireless monitors were used to quantify the amount of mobility that occurs daily for each patient with researchers being blinded to the outcome.
|
During hospital stay
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Life-Space Assessment Score
Time Frame: 4-6 weeks after baseline
|
The UAB Study of Aging Life-Space Assessment (LSA) is a validated tool that measures mobility and function based on the distance which a person reports moving during the four weeks preceding the assessment.
Life-space "levels" range from within one's dwelling to beyond one's town.
A life-space composite score is calculated based on life-space level, degree of independence in achieving each level, and the frequency of attaining each level.
Scores range from 0 - 120 with higher scores indicating greater community mobility.
|
4-6 weeks after baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: Cynthia J. Brown, MD MSPH, VA Medical Center, Birmingham
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E6326-W
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Disease
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host DiseaseUnited States
-
Hospital de Clinicas de Porto AlegreRecruitingCritical Illness | Acute Kidney Injury | Fluid Overload | Renal Insufficiency, Acute | Volume Overload | Kidney; Disease, AcuteBrazil
-
Sheba Medical CenterUnknownStem Cell Transplant Complications | Fecal Microbiota Transplantation | Graft Versus Host Disease, AcuteIsrael
-
Ruijin HospitalNot yet recruitingAcute Graft vs Host Disease | Acute Graft Versus Host Disease Grade II-IV
-
EquilliumBiocon LimitedCompletedGVHD | GVHD, Acute | aGVHD | Acute-graft-versus-host DiseaseUnited States
-
EquilliumBiocon LimitedTerminatedGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Spain, Korea, Republic of, Italy, Canada, Germany, Belgium, Israel, Australia, France, Portugal, New Zealand
-
Jonsson Comprehensive Cancer CenterWithdrawnAcute Graft Versus Host Disease | Gastrointestinal Tract Acute Graft Versus Host Disease | Severe Gastrointestinal Tract Acute Graft Versus Host Disease | Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host DiseaseUnited States
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.TerminatedAcute Myeloid Leukemia | Acute Leukemia | Acute Leukemia in Relapse | Relapsed or Refractory Acute LeukemiaChina
-
University of PisaCompletedHematopoietic Stem Cell Transplantation | Graft Versus Host Disease, AcuteItaly
Clinical Trials on Behavioral intervention
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brown... and other collaboratorsRecruiting
-
Pennington Biomedical Research CenterThe Coca-Cola CompanyCompletedParent-targeted Mobile Phone Based Intervention to Increase Physical Activity in Children (P-Mobile)Physical ActivityUnited States
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
National Taiwan University HospitalUnknown
-
Roswell Park Cancer InstituteCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)Active, not recruitingSleep | Sleep Disturbance | Attention Deficit and Disruptive Behavior Disorders | Attention Deficit Hyperactivity Disorder | Child, PreschoolUnited States
-
New York State Psychiatric InstituteCompletedPostpartum DepressionUnited States
-
Aikaterini KaraivazoglouUniversity of Eastern Finland; Savonia University of Applied SciencesNot yet recruitingObesity (Disorder)Greece, Italy, Sweden
-
Rush University Medical CenterUniversity of Chicago; National Institute on Aging (NIA); Advocate Hospital SystemActive, not recruitingStroke | Dementia | Alzheimer Disease | Dementia, Vascular | Cognitive DeclineUnited States